Abu Dhabi:M42, a global leader in health powered by AI, technology, and genomics, has entered into a partnership with Siemens Healthineers, a prominent medical technology company, to advance healthcare transformation across the Global South, particularly focusing on Africa. The partnership was formalized through a Memorandum of Understanding (MoU) signed at the Abu Dhabi Future Health Summit 2026 (ADFHS).
According to Wam, the MoU was signed by Kareem Shahin, CEO of Digital Health Solutions Platform and Group Chief Digital Officer at M42, and Dr. Kevin Massoudi, Vice President and Head of Public Sector at Siemens Healthineers, Middle East and Africa. The agreement seeks to explore joint value propositions and technology-enabled solutions aimed at strengthening disease prevention, screening, and earlier detection.
The collaboration aims to enable more proactive approaches to population health, helping health systems identify health risks earlier for timely intervention. Dimitris Moulavasilis, Group Chief Executive Officer of M42, emphasized the importance of reducing health inequities and the commitment to scaling innovation to overcome healthcare challenges. The partnership is expected to leverage M42's digital health capabilities and Siemens Healthineers' expertise in medical imaging and diagnostics.
The initiative will benefit from M42's experience with platforms like Malaffi, Sahatna, and the E-Prescriptions platform, which are complemented by AI-driven analytics. Siemens Healthineers will contribute its proficiency in medical imaging, diagnostics, and minimally invasive therapies, focusing on improving access and efficiency in healthcare.
Kareem Shahin highlighted the ambition to explore new ways to strengthen prevention and screening by connecting digital health data and AI with advanced medical technologies. Dr. Kevin Massoudi expressed the potential of the collaboration to support earlier diagnosis and treatment, aiming to elevate healthcare in the UAE and emerging markets, including Africa.
The partnership supports M42’s international expansion and reinforces Abu Dhabi’s position as a hub for AI-driven healthcare innovation, with Africa and the wider Global South being priorities for this growth.
